Get started
Author

Bhavesh Pant

Observed institution: Central University of Rajasthan
ORCID: 0000-0002-7053-3481
Observed ORCID: 0000-0002-7053-3481
OpenAlex ID: A5060001183
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
2021 · Ye Wang, Morvarid Mohseni, et al. · Scientific Reports · 76
PDF
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2019 · Huai-Xiang Hao, Hongyun Wang, et al. · Molecular Cancer Therapeutics · 55
Creation of pure longitudinal super-oscillatory spot
2023 · Bhavesh Pant, Hemant Kumar Meena, et al. · Optics Letters · 5
Controlled experimental generation of perturbed high-order Ince–Gaussian laser modes
2023 · Hemant Kumar Meena, Bhavesh Pant, et al. · Journal of the Optical Society of America A · 1
Adaptation, Not Translation: An Architecture and Evaluation Framework for Long-Form Cross-Cultural Story Localization
2026 · Taaha Kazi, Aditya Sanjiv Kanade, et al. · Conference on Empirical Methods in Natural Language Processing (EMNLP)
PDF
Figure S4 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Table S2 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Table S4 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Table S3 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Fig S1 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
PDF
Supplementary Material and Methods from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Figure S3 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Figure S2 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
PDF
Table S1 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Fig S1 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Figure S2 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Figure S3 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
PDF
Figure S4 from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
PDF
Data from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
2023 · Huai-Xiang Hao, Hongyun Wang, et al.
Works count: 19
Citation count: 137
H-index: 3
I10-index: 2
Year
Topic
Type